Condition: Neuropathic Pain · Chronic Pain · Sponsor: University Hospital, Brest
Patients aged less than 18-y with validated 8% capsaicin patch treatment in routine healthcare will be offered to participate the study. If they accept it as well as their parents, they will be included in the study . Medical data will be recorded and at home, the child or his family will collect pain assessment data. Tolerance will be monitored at home by phone call from investigational team every 24 hours until normalization. (Less than 24 hours for 75%, 100% to 72 hours on unpublished personal series.) Children will be assessed via scales at inclusion and 1-month, 3-month and 6-month.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| CHU Angers | Angers, France, France | — |
| CHU Bordeaux | Bordeaux, France, France | — |
| CHR Bourg en Bresse | Bourg-en-Bresse, France, France | — |
| CHU de Brest | Brest, France, France | — |
| CHU Caen | Caen, France, France | — |
| CHU Lille | Lille, France, France | — |
| CHU Limoges | Limoges, France, France | — |
| CHU Marseille | Marseille, France, France | — |
| CHU Montpellier | Montpellier, France, France | — |
| CHU Nancy | Nancy, France, France | — |
| CHU Nantes | Nantes, France, France | — |
| CHU Robert Debré | Paris, France, France | — |
+ 8 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.